EnGeneIC Ltd. (ABN: 59 091 336 499) — Form D/A
EnGeneIC Ltd. (ABN: 59 091 336 499) of LANE COVE, NEW SOUTH WALES, C3, a company, filed a Form D amendment with the SEC on 2011-07-27. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-07-27
- Form: D/A
- Accession: 0000897069-11-000295
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 2
- Date of first sale: 2011-05-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-161005
Issuer
- Name: EnGeneIC Ltd. (ABN: 59 091 336 499)
- CIK: 0001522586
- Entity type: Other
- Jurisdiction: AUSTRALIA
- Address: BUILDING 2, LANE COVE, NEW SOUTH WALES, C3, 2066
- Phone: 61 2 9420 5844
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Ergad Gold | Director | Melbourne Victoria, C3 |
| Robert Graham | Director | Atlanta, GA |
| Roger Moore | Director | Fort Lauderdale, FL |
| Graham Cole | Executive Officer | Lane Cove, New South Wales, C3 |
| Richard Woods | Director | Lebanon, NH |
| David Seaton | Executive Officer | New South Wales, C3 |
| Himanshu Brahmbhatt | Director | New South Wales, C3 |
| Himanshu Brahmbhatt | Executive Officer | New South Wales, C3 |
| Jennifer MacDiarmid | Director | New South Wales, C3 |
| Jennifer MacDiarmid | Executive Officer | New South Wales, C3 |
| Anjan Chatterji | Executive Officer | New York, NY |
| William Louis Delaat | Director | New South Wales, C3 |
| Stuart Wardman-Browne | Director | Sidney, C3 |
| Mervyn John Turner | Director | New South Wales, C3 |
Other filings by this issuer (3)
More